Choludexan
← AllCholudexan and viral hepatitis: what is common?
Published in the journal «District Doctor» October-November’2017
Read morePrimary biliary cholangitis: innovation and consistency in the EASL guidelines
Published in a journalе «District doctor» May-June’2017
Read moreUDCA and “large” cholestatic liver diseases
Published in the journal «District Doctor» april’2017
Read more«Dissolution» of gall stones: dreams or reality?
Published in a journal «District doctor» мarch’2017
Read morePathogenetic reasons for use of hepatoprotector with approval clinical efficancy – ursodeoxycholic ACID: from discovery history to evidence base
Published in a journal «District doctor» february’2017
Read moreMetabolic syndrome: state of the problem and approaches to therapy
Published in the journal «Modern gastroenterology» № 2 (94)’2017
Read moreGallbladder dysfunction and biliary sludge: clinical implications and current treatment approaches
Published in the journal «Modern gastroenterology» № 5 (61)’2011
Read moreStudy of the spectrum of bile acids in patients with non-alcoholic fatty liver disease in combination with hyperuricemia
Published in the journal «Practitioner» № 4’2014
Read moreCholestasis in pregnant women: problem or condition?
Published in the journal «District Doctor» № 7’2014
Read moreTreatment of gallbladder cholesterosis in patients with type 2 diabetes mellitus using ursodeoxycholic acid
Published in the journal «Problems of Endocrine Pathology» № 4’2012
Read more